Xu Jinbo Leads Molecular Heart in $100M+ Round to Define AI Protein Infrastructure
量子位 QbitAI41 days agoBusinessMolecular Heart (分子之心), the AI-driven protein technology company helmed by computational biologist Xu Jinbo, has completed a financing round exceeding $100 million USD. The raise is framed not as a single-product bet but as a platform play to establish foundational infrastructure for the global AI protein industry. The announcement signals that large-scale capital continues to consolidate around researchers-turned-founders with deep domain credibility in the AI-biology convergence.
兩款 AI 科學助手成功完成「老藥新用」任務★ 70
Ars Technica AI69 days agoPaperThis report explores the latest breakthroughs made by AI science assistants in the field of "drug repurposing" (also known as drug retargeting — finding new…
Google DeepMind 推出 Co-Scientist：加速肝臟疾病機制研究與個人化藥物開發★ 80
Google DeepMind Blog73 days agoReleaseThis latest case study from Google DeepMind details how AI is playing a pivotal role in the biomedical field. Professor Filippo Menolascina of the University…
AlphaFold 成功解析心臟病關鍵蛋白質結構，為心血管疾病治療帶來新突破★ 80
Google DeepMind Blog244 days agoReleaseGoogle DeepMind recently announced that AlphaFold, its revolutionary protein structure prediction tool, has achieved a major breakthrough in medicine by…
SandboxAQ 推出 SAIR 數據集：以 AI 結構智能加速製藥研發★ 72
Hugging Face Blog328 days agoReleaseSandboxAQ — an AI and quantum technology pioneer spun out of Alphabet — has officially launched an open-source dataset called SAIR (Structural AI for Research)…